CUTENOX 60MG INJECTION

Same day

Introduction:

Cutenox 60mg Injection contains the active constituent enoxaparin. It is used to treat and prevent blood clots. This medication can be given before or after major surgery, or when you have chest pain, cancer, or after a heart attack to stop the existing clots from getting any bigger or formation of new blood clots.

 

Before taking Cutenox 60mg Injection, inform your doctor if you have any heart problems, gastric ulcer, high blood pressure, diabetes, kidney disorders, liver disorders, have had a recent stroke, or an operation recently on the brain or eyes. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.

 

Uses of Cutenox 60mg Injection:

  • Treats and prevents blood clots

 

How Cutenox 60mg Injection works:

Enoxaparin binds to the antithrombin (a protein that blocks abnormal blood clots formation) and forms a complex. This complex irreversibly inactivates the factor Xa (factor involved in the clot formation) and prevents clot formation.

 

Interactions with other drugs:

Inform your doctor about any medications you are taking or have taken before the treatment.

 

More information:

  • Keep Cutenox 60mg Injection out of sight and reach of children.
  • Do not store above 25°C. Do not freeze.

 

References:

  1. KD Tripathi, Essentials of Medical Pharmacology, Drugs affecting coagulation, bleeding, and thrombosis, 7th edition, 2013, 619.
  2. Sanofi, Electronic medicines compendium (emc), [ Revised on Sept 2021] [ Accessed on 8th Dec 2021], https://www.medicines.org.uk/emc/files/pil.4499.pdf
  3. Sanofi-aventis US LLC, US Food and Drug Administration, [ Revised on Dec 2009] [ Accessed on 8th Dec 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020164s085lbl.pdf
  4. Thomas Hofmann; Clinical application of enoxaparin; Expert Review of Cardiovascular Therapy; Published on May 2004; Accessed on 08/12/2021; https://pubmed.ncbi.nlm.nih.gov/15151480/
  5. Aamani Jupalli, Arshad Muhammad Iqbal; Enoxaparin; Updated on 08/09/2021; Accessed on 08/12/2021; https://www.ncbi.nlm.nih.gov/books/NBK539865/#_NBK539865_pubdet_

Disclaimer: City Medicine Corner primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on City Medicine Corner. Our mission is to support, not replace, the doctor-patient relationship.

Enquiry Now

SUBMIT NOW